0001542968-15-000001.txt : 20150619
0001542968-15-000001.hdr.sgml : 20150619
20150619135049
ACCESSION NUMBER: 0001542968-15-000001
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150617
FILED AS OF DATE: 20150619
DATE AS OF CHANGE: 20150619
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARGOS THERAPEUTICS INC
CENTRAL INDEX KEY: 0001105533
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 562110007
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4233 TECHNOLOGY DR
CITY: DURHAM
STATE: NC
ZIP: 27704
BUSINESS PHONE: 9192876300
MAIL ADDRESS:
STREET 1: 4233 TECHNOLOGY DR
CITY: DURHAM
STATE: NC
ZIP: 27704
FORMER COMPANY:
FORMER CONFORMED NAME: MERIX BIOSCIENCE INC
DATE OF NAME CHANGE: 20000207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Plessinger Douglas C.
CENTRAL INDEX KEY: 0001542968
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35443
FILM NUMBER: 15941964
MAIL ADDRESS:
STREET 1: 4233 TECHNOLOGY DRIVE
CITY: DURHAM
STATE: NC
ZIP: 27704
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2015-06-17
0
0001105533
ARGOS THERAPEUTICS INC
ARGS
0001542968
Plessinger Douglas C.
4233 TECHNOLOGY DRIVE
DURHAM
NC
27704
0
1
0
0
See Remarks
Stock Option (right to buy)
7.8
2015-06-17
4
A
0
30000
0
A
2025-06-16
Common Stock
30000
30000
D
This option was granted on June 17, 2015 and vests as to 25% of the shares underlying this option on June 17, 2016, with the remaining 75% of the shares underlying this option vesting in equal amounts monthly over the next three years beginning June 17, 2016.
Vice President of Clinical and Medical Affairs
Lori R. Harrelson, as attorney-in-fact
2015-06-19